Skip to main content
Family Medicine
ALL Specialities
ALL Specialities
/
Family Medicine
CME
COVID-19 Updates
The Journal of Family Practice
Current Issue
Past Issues
Author Guidelines
Specialties
Addiction Medicine
Cardiology
Dermatology
Diabetes
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pain
Pediatrics
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
For Residents
Residents' Rapid Review
Multimedia
Audio
All Podcasts
Practice Alert Podcast
Video
3-in-3
Watch & Learn
Guidelines
New guidelines update VTE treatment recommendations
Publish date:
January 8, 2016
FROM CHEST
References
msullivan@frontlinemedcom.com
Pages
« first
1
2
Recommended Reading
New composite measure improves warfarin anticoagulation monitoring
MDedge Family Medicine
TCT: Novel drug-coated stent bests bare-metal in patients at high bleeding risk
MDedge Family Medicine
For subacute STEMI, thrombectomy adds no benefit to PCI
MDedge Family Medicine
Idarucizumab approved as first agent to reverse a novel oral anticoagulant
MDedge Family Medicine
FDA finds long-term clopidogrel does not increase death or cancer risks
MDedge Family Medicine
Andexanet reverses anticoagulant effects of factor Xa inhibitors
MDedge Family Medicine
AHA: DAPT score helps decide whether DAPT continues
MDedge Family Medicine
FDA okays prophylactic Pradaxa for VTE in hip replacement
MDedge Family Medicine
AHA: DAPT prevents migraines after atrial-septal defect closure
MDedge Family Medicine
Study characterizes intracerebral hemorrhage with new oral anticoagulants
MDedge Family Medicine
Cardiology
Hematology
All Specialties